Early assessment of visual information processing and neurological outcome in preterm infants

A Guzzetta1, S Mazzotti, F Tinelli

  • 1Department of Developmental Neuroscience, Stella Maris Scientific Institute, Pisa, Italy.

Neuropediatrics
|January 20, 2007
PubMed

Insights

The Fagan Test of Infant Intelligence shows promise for predicting neurodevelopmental outcomes in high-risk infants. Nine months postterm is the optimal age for this assessment due to improved visual and attentional system maturation.

Area of Science:

  • Neurodevelopmental studies
  • Infant psychology
  • Visual information processing

Background:

  • Psychological tests assessing visual information processing are valuable for predicting neurodevelopmental outcomes in at-risk infants.
  • Early identification of developmental trajectories in high-risk preterm infants is crucial for timely intervention.

Purpose of the Study:

  • To prospectively investigate the predictive value of the Fagan Test of Infant Intelligence (FTII) and visual function assessments in high-risk preterm infants.
  • To determine the optimal postterm age for assessing neurodevelopmental outcomes using visual processing tests.

Main Methods:

  • Prospective study of 20 high-risk preterm infants.
  • Utilized the Fagan Test of Infant Intelligence at 7, 9, and 12 months postterm.
  • Administered a detailed visual function assessment battery at 6 and 10 months postterm.
  • Correlated FTII results with Griffiths development scales at two years.

Main Results:

  • No significant correlation between the FTII and neurodevelopmental outcome at 7 months, potentially due to oculomotor abnormalities.
  • A significant correlation emerged at 9 months, coinciding with the resolution of most visual abnormalities.
  • A decline in the FTII's predictive value was observed at 12 months postterm.

Conclusions:

  • Nine months postterm is the optimal age for early neurodevelopmental assessment in high-risk preterm infants using the FTII.
  • Maturation of visual and attentional systems by 9 months allows for more reliable predictions.
  • The FTII, when administered around 9 months, serves as a valuable tool for predicting long-term neurodevelopmental outcomes.